Abstract:The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is an evolving DNA-sensing mechanism involved in innate immunity and pathogen defense that has been optimized while remaining conserved. Aside from recognizing pathogens through conserved motifs, these receptors also detect aberrant or misplaced self-molecules as possible signs of perturbed homeostasis. Upon binding external or self-derived DNA, a mobile secondary messenger 2′3′-cyclic GMP-AMP (cGAMP) is produced by cGAS and in turn activates its adapter STING in the endoplasmic reticulum (ER). Resting-state or activated STING protein is finely restricted by multiple degradation machineries. The post-translational changes of the STING protein, along with the regulatory machinery of the secret routes, limit the onset, strength and sustention of STING signal. STING experiences a conformational shift and relocates with TBK1 from the ER to perinuclear vesicles containing transcription factors, provoking the transcription activity of IRF3/IFN-I and NF-κB pathways, as well as to initiate a number of cellular processes that have been shown to alter the immune landscape in cancer, such as autophagy, NLRP3 inflammasome, ER stress, and cell death. STING signal thus serves as a potent activator for immune mobilization yet also triggers immune-mediated pathology in tissues. Recent advances have established the vital role of STING in immune surveillance as well as tumorigenic process. This review provides an overview of the disparate outcomes of cancer attributed to the actions of pleiotropic and coordinated STING downstream signalosomes, along with the underlying mechanisms of STING function in pathologies, providing therapeutic implications for new approaches in hunt for the next generation of cancer immunotherapy base on STING.

Trapping microfluidic drops in wells of surface energy.

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies

cGAS-STING pathway in cancer biotherapy

Mini-review: the distinct roles of STING signaling in tumor immunity-recent progress

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

Strategies involving STING pathway activation for cancer immunotherapy: mechanism and agonists

Role of micronucleus-activated cGAS-STING signaling in antitumor immunity

Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy

GAS-STING: a classical DNA recognition pathways to tumor therapy

Cellular functions of cGAS-STING signaling

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors

Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies

DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling

Advances in the Prerequisite and Consequence of STING Downstream Signalosomes

Cgas and Cancer Therapy: a Double-Edged Sword

The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer

An Analysis of the Expression and Association with Immune Cell Infiltration of the Cgas/sting Pathway in Pan-Cancer

Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy